RGW-611
UNII 7QC7E66DRA

Substance Identification & Data

This profile provides standardized clinical and technical data for Rgw-611, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7QC7E66DRA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 6497-78-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7QC7E66DRA
CAS Registry Number
6497-78-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RGW-611
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C9H14N4O3
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
VDZAAIIQCHGJAD-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C(CN1CCOCC1)n2cc([N+]([O-])=O)nc2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rgw-611. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

4-(2-(4-NITRO-1H-IMIDAZOL-1-YL)ETHYL)MORPHOLINE
MORPHOLINE, 4-(2-(4-NITRO-1H-IMIDAZOL-1-YL)ETHYL)-
MORPHOLINE, 4-(2-(4-NITROIMIDAZOL-1-YL)ETHYL)-

Technical Codes

RGW611
RGW-611